Penn Medicine, University of Pennsylvania Health System’s Post

We're excited to renew our collaboration with the Parker Institute for Cancer Immunotherapy (PICI) to advance cancer immunotherapy research at Penn Medicine’s Abramson Cancer Center. “Being part of PICI has opened new doors for teamwork across institutions that has already proved to be very fruitful in moving immunotherapy forward as a pillar of cancer treatment,” said Carl June, MD, the Richard W. Vague Professor in Immunotherapy and director of the Parker Institute for Cancer Immunotherapy Center at Penn. Learn how this continued alliance will help support discovery science and the advancement of new therapies: http://spr.ly/6046m8WpG

  • No alternative text description for this image

"Impressive work, Dr. June and the PICI team! Collaborations like this are essential in driving innovation in cancer treatment. Excited to see how these advancements will continue to push the boundaries of immunotherapy. Looking forward to the future breakthroughs this partnership will bring!"

Marc Thomas, R.N.

President of Allergy Information Services (A.I.S.)

2mo

I’m glad to see this initiative moving forward!

Like
Reply
Margaret R.

Critical Care Registered Nurse

2mo

Moving forward! Congratulations!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics